Metaraminol

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H13NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 818U2PZ2EH, chemically known as benzyl alcohol, alpha-(1-aminoethyl)-m-hydroxy-, (-)- but generally known as metaraminol, which bears US NIH Compound Identifier 5906. European Medicines Agency schedules Metaraminol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08815MIG. The term METARAMINOL is an International Non-Proprietary Name. World Health Organization schedules metaraminol in its Anatomical Therapeutic Chemical (ATC) Classification. METARAMINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metaraminol under HS 29399900 and SITC 54149. As of Q4 2014, METARAMINOL remains the US FDA Preferred Term for this commodity. Metaraminol bears US NLM identifiers UMLS ID C0025575 and NCI Concept Code C61835. SMILES: OC(C(N)C)C1CC(O)CCC1.